Legal Disclaimers & Attributions
Important information about content, testimonials, and clinical data on this website
Medical Disclaimer
The information provided on this website is for general informational and educational purposes only. It is not intended as, and should not be construed as, medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The London Weight Loss Clinic does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the site.
Individual results may vary. Weight loss outcomes depend on various factors including adherence to treatment protocols, individual metabolism, lifestyle changes, and medical history.
Testimonials & Success Stories
Testimonials and success stories displayed on this website represent the experiences of individual patients. These are genuine accounts from real patients who have consented to share their stories. For privacy protection, some names may be abbreviated or represented by initials.
Important: These testimonials are not intended to guarantee that everyone will achieve the same results. Individual results will vary based on factors including but not limited to:
- Starting weight and BMI
- Adherence to prescribed treatment
- Dietary and lifestyle changes
- Individual metabolic factors
- Pre-existing medical conditions
- Duration of treatment
The testimonials on this site do not constitute a guarantee, warranty, or prediction regarding the outcome of any consultation or treatment.
Clinical Data & Research Citations
Statistics and clinical data referenced on this website are derived from peer-reviewed clinical trials and published medical research. Key sources include:
GLP-1 Medication Research
- Tirzepatide (Mounjaro): SURMOUNT-1 Trial - Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216
- Semaglutide (Wegovy): STEP 1 Trial - Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002
- Liraglutide (Saxenda): SCALE Obesity and Prediabetes Trial - Pi-Sunyer X, et al. N Engl J Med. 2015;373:11-22
The "53% more weight loss" statistic refers to patients receiving GLP-1 medication combined with comprehensive lifestyle coaching versus medication alone, as observed in comparative outcomes research.
Programme-specific statistics (e.g., 97% patient satisfaction, 21.55% average weight loss) are based on internal patient surveys and anonymised outcome tracking conducted by The London Weight Loss Clinic. These figures represent aggregated data and do not guarantee individual outcomes.
Image Credits & Licences
Images used on this website are obtained from the following sources:
Unsplash
Photographs used under the Unsplash Licence, which permits free use for commercial and non-commercial purposes. No attribution required but photographers may be credited where practical. View Unsplash Licence
AI-Generated Images
Certain illustrative images on this website have been generated using artificial intelligence tools. These images are used for educational and illustrative purposes only and do not depict real individuals unless explicitly stated.
Product Images
Medication images (Mounjaro, Wegovy, Saxenda, Orlistat) are used for informational purposes. Product names and trademarks belong to their respective manufacturers: Eli Lilly (Mounjaro), Novo Nordisk (Wegovy, Saxenda), and various manufacturers (Orlistat).
Original Content
Photographs of The London Weight Loss Clinic team, facilities, and branded materials are proprietary and © 2026 The London Weight Loss Clinic. All rights reserved.
Content & Copyright
All original content on this website, including but not limited to text, graphics, logos, button icons, images, audio clips, digital downloads, and data compilations, is the property of The London Weight Loss Clinic or its content suppliers and is protected by UK and international copyright laws.
Educational and informational content on this website has been prepared by qualified healthcare professionals and medical writers. While we strive to ensure accuracy, medical knowledge evolves and information may become outdated. Content is reviewed and updated periodically.
Third-Party Content: Where content references third-party research, publications, or information, appropriate citations are provided. Such content remains the intellectual property of the original creators and is used in accordance with fair use principles for educational purposes.
Trademark Acknowledgements
The following trademarks are the property of their respective owners and are used on this website for identification purposes only:
- Mounjaro® and Tirzepatide are trademarks of Eli Lilly and Company
- Wegovy®, Ozempic®, and Saxenda® are trademarks of Novo Nordisk A/S
- Sappetite® is a trademark of its respective owner
- Trustpilot® is a trademark of Trustpilot A/S
The London Weight Loss Clinic is not affiliated with, endorsed by, or sponsored by any of the above trademark owners unless explicitly stated. Use of these trademarks does not imply any affiliation or endorsement.
Copyright Concerns?
If you believe any content on this website infringes your copyright or intellectual property rights, please contact us immediately at:
Email: [email protected]
Please provide: (1) Identification of the copyrighted work, (2) Location of the allegedly infringing material on our website, (3) Your contact information, and (4) A statement of good faith belief that the use is not authorised.
Last updated: 2 February 2026
